急诊胸痛评估(EDACS)评分诊断准确性的系统评价与Meta分析
该系统评价与Meta分析纳入8项诊断准确性研究(11,578例)和1项RCT(558例),评估EDACS评分对急诊疑似ACS患者的诊断准确性与安全性。汇总敏感度96.1%(95%CI 89.6%–98.6%),特异度61.1%(95%CI 55.5%–66.3%);作者结论为EDACS可在2小时内连续肌钙蛋白采样后识别超过50%的疑似ACS患者适合离院,总体敏感度较高、可能为临床接受。
要点
- 汇总敏感度96.1%(95%CI 89.6%–98.6%)、特异度61.1%(95%CI 55.5%–66.3%),用于急诊疑似ACS患者30天MACE。
- 低危离院的前提是完成2小时内连续肌钙蛋白采样,这是原文结论中明确的条件。
- 证据来自8项诊断准确性研究(11,578例)加1项RCT(558例),采用随机效应模型汇总。
- 低危组仍有0.54%的30天MACE,不能把EDACS低危等同于零风险。
适用人群与场景
- 因疑似急性冠脉综合征到急诊就诊的患者,为8项诊断准确性研究与1项RCT所纳入的人群。
诊断标准与关键阈值
- 评估工具为急诊胸痛评估(EDACS)评分,原文未给出评分各项条件与界值。
- 低危判定需结合2小时内连续肌钙蛋白采样,原文未给出具体肌钙蛋白阈值。
处置流程与药物剂量
- 第一步:对急诊疑似ACS患者计算EDACS评分。
- 第二步:对EDACS判为低危者,在2小时内完成连续肌钙蛋白采样。
- 第三步:采样后符合条件者考虑早期离院;原文未给出具体药物、剂量或后续治疗方案。
红旗征与不能漏的情况
- 原文未提及其他红旗征或需立刻处理的情况。
研究设计与关键结果
- 研究类型为系统评价与Meta分析,纳入8项诊断准确性研究(11,578例)和1项RCT(558例)。
- 主要终点为30天内主要不良心脏事件(MACE)。
- 汇总敏感度96.1%(95%CI 89.6%–98.6%),特异度61.1%(95%CI 55.5%–66.3%),采用随机效应模型。
- 原文未报告关键次要终点与不良事件的具体数据。
证据类型、等级与局限
- 证据类型为系统评价与Meta分析(含诊断准确性研究与1项RCT)。
- 局限性:原文未明确列出,仅提及采用随机效应模型评估异质性。
对床旁实践的改变
- 支持对急诊疑似ACS患者使用EDACS评分联合2小时内连续肌钙蛋白采样来筛选可早期离院者。
- 低危组30天MACE为0.54%,提示离院决策仍需结合肌钙蛋白结果,不能仅凭EDACS低危。
- 原文未提及适用与不适用人群的进一步限定,也未提及其他具体做法改变。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: We evaluate current evidence for the diagnostic accuracy and safety of the Emergency Department Assessment of Chest Pain Score (EDACS) for patients presenting to the emergency department (ED) with possible acute coronary syndromes.
METHODS: MEDLINE, EMBASE, and Cochrane databases were searched for publications reporting data on the EDACS score. No date restrictions were used. Two independent researchers assessed studies for eligibility, bias, and quality. The primary outcome was major adverse cardiac events occurring within 30 days. Heterogeneity was assessed and data were pooled by meta-analysis using a random-effects model.
RESULTS: Eight diagnostic test accuracy studies including 11,578 patients and 1 randomized controlled trial including 558 patients were eligible for inclusion. On meta-analysis, the EDACS score had a pooled sensitivity of 96.1% (95% confidence interval 89.6% to 98.6%) and specificity of 61.1% (95% confidence interval 55.5% to 66.3%). A total of 55.0% of patients (n=6,370/11,578) were identified as low risk and eligible for early discharge. Sixty-two patients (0.54%) identified as low risk had an outcome of major adverse cardiac events within 30 days.
CONCLUSION: The EDACS score identified greater than 50% of patients with suspected acute coronary syndrome as suitable for discharge after serial troponin sampling during 2 hours. Sensitivity for major adverse cardiac events was relatively high overall and may be acceptable to clinicians.
参考来源
- Boyle RSJ, Body R. The Diagnostic Accuracy of the Emergency Department Assessment of Chest Pain (EDACS) Score: A Systematic Review and Meta-analysis. Ann Emerg Med. 2021. PMID: 33461885. doi:10.1016/j.annemergmed.2020.10.020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。